Circle Pharma closes $45M series B financing led by The Column Group to support its macrocycle drug development work. [...]
Circle Pharma congratulates 2019 Nobel laureate Dr. Bill Kaelin. Dr. Kaelin advises Circle on its work to develop cyclin inhibitors for cancer., [...]
Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.
Results from its collaborative work with Pfizer to develop a potent and orally bioavailable macrocycle modulator have been published [...]
Circle Pharma Announces Receipt of Additional Seed Investment, and Relocation to New Laboratory Facility
The seed funding round has been extended with an investment from ShangPharma Investment Group [...]
Circle Pharma has received seed funding from Pfizer Inc. and QB3’s seed-stage venture fund, Mission Bay Capital, LLC, and has initiated two collaborations with Pfizer [...]